Sequential, Multiple Assignment, Randomized Trial Designs With Dr Kidwell

Sequential, Multiple Assignment, Randomized T...

Up next

Pattern-Mixture Models for Missing Data With Dr Little

Roderick Little, PhD, University of Michigan School of Public Health Departments of Epidemiology & Biostatistics discusses Pattern-Mixture Models for Missing Data with Roger J. Lewis, MD, PhD, statistical editor for JAMA. Related Content: Pattern-Mixture Models for Missing Data 

Interpretation of Clinical Trials That Stopped Early With Dr Viele

Kert Viele, PhD, director and senior statistical scientist at Berry Consultants, discusses "Interpretation of Clinical Trials That Stopped Early" with JAMA Statistical Editor Roger J. Lewis, MD, PhD. Related Content: Interpretation of Clinical Trials That Stopped Early 

Recommended Episodes

Using Real-World Studies to Compare DMTs in MS
The ECTRIMS Podcast

Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, and Maria Pia Sormani, Professor of Biostatistics at the University of Genoa, discuss the use of real-world data to compare disease-modifying treatments (DMTs) in multiple sclerosis, inclu ...  Show more

Patient-Reported Outcomes in Clinical Trials
JAMA Clinical Reviews

JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ...

  Show more

Binocular iPad Game vs Patching for Treatment of Amblyopia in Children
JAMA Ophthalmology Author Interviews

Interview with Krista R. Kelly, PhD, author of Binocular iPad Game vs Patching for Treatment of Amblyopia in Children: A Randomized Clinical Trial 

Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
JACC This Week

Michelle M Kittleson, MD, FACC, JACC Associate Editor, speaks with author Muthiah Vaduganathan, MD on his accepted paper concerning the FINEARTS trial published in JACC.